Preclinical evaluations of PF-00868554, a potent non-nucleoside inhibitor of the hepatitis C virus RNA polymerase

被引:0
|
作者
Shi, Stephanie [1 ]
Herlihy, Koleen [1 ]
Irvine, Rebecca [1 ]
Binford, Susan [1 ]
Lewis, Cristina [1 ]
Nonomiya, Jim [1 ]
Patick, Amy [1 ]
机构
[1] Pfizer, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1394
引用
收藏
页码:858A / 859A
页数:2
相关论文
共 50 条
  • [41] Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase (vol 55, pg 2481, 2012)
    Sofia, Michael J.
    Chang, Wonsuk
    Furman, Phillip A.
    Mosley, Ralph T.
    Ross, Bruce S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (07) : 3219 - 3219
  • [42] Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections
    Jin, Young-Hee
    Min, Jung Sun
    Jeon, Sangeun
    Lee, Jihye
    Kim, Seungtaek
    Park, Tamina
    Park, Daeui
    Jang, Min Seong
    Park, Chul Min
    Song, Jong Hwan
    Kim, Hyoung Rae
    Kwon, Sunoh
    PHYTOMEDICINE, 2021, 86
  • [43] Rational design and optimization of acylthioureas as novel potent influenza virus non-nucleoside polymerase inhibitors
    Liu, Xinjin
    Xu, Zhichao
    Liang, Jinsen
    Xu, Ting
    Zou, Wenting
    Zhu, Lijun
    Wu, Yihe
    Dong, Chune
    Lan, Ke
    Wu, Shuwen
    Zhou, Hai-Bing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
  • [44] CC-31244, A NOVEL, PAN-GENOTYPIC, POTENT NS5B NON-NUCLEOSIDE POLYMERASE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS C
    Jacobson, I.
    Feese, M.
    Xiao, H.
    Uher, L.
    Lin, B.
    Sanchez, E.
    Tomkiewicz, R.
    Whitaker, T.
    McBrayer, T.
    Pascual, L.
    Pattassery, J.
    Lee, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S421 - S422
  • [45] IDENTIFICATION AND CHARACTERIZATION OF VCH-222, A NOVEL POTENT AND SELECTIVE NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR
    Bedard, J.
    Nicolas, O.
    Bilimoria, D.
    L'Heureux, L.
    Fex, P.
    David, M.
    Chan, L.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S340 - S340
  • [46] Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors
    Ma, H
    Leveque, V
    De Witte, A
    Li, WX
    Hendricks, T
    Clausen, SM
    Cammack, N
    Klumpp, K
    VIROLOGY, 2005, 332 (01) : 8 - 15
  • [47] Identification and Characterization of Pyrimidinediones as Potent Non-nucleoside Reverse Transcriptase Inhibitors of Hepatitis B virus
    Yang, Lu
    Parsley, Todd
    Buckheit, Robert, Jr.
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A32 - A32
  • [48] Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model
    Chen, Chih-Ming
    He, Yupeng
    Lu, Liangjun
    Ben Lim, Hock
    Tripathi, Rakesh L.
    Middleton, Tim
    Hernandez, Lisa E.
    Beno, David W. A.
    Long, Michelle A.
    Kati, Warren M.
    Bosse, Todd D.
    Larson, Daniel P.
    Wagner, Rolf
    Lanford, Robert E.
    Kohlbrenner, William E.
    Kempf, Dale J.
    Pilot-Matias, Tami J.
    Molla, Akhteruzzaman
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) : 4290 - 4296
  • [49] The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C
    Zeuzem, Stefan
    Buggisch, Peter
    Agarwal, Kosh
    Marcellin, Patrick
    Sereni, Daniel
    Klinker, Hartwig
    Moreno, Christophe
    Zarski, Jean-Pierre
    Horsmans, Yves
    Mo, Hongmei
    Arterburn, Sarah
    Knox, Steven
    Oldach, David
    McHutchison, John G.
    Manns, Michael P.
    Foster, Graham R.
    HEPATOLOGY, 2012, 55 (03) : 749 - 758
  • [50] PRECLINICAL POTENCY, PHARMACOKINETIC AND ADME CHARACTERIZATION OF ABT-333, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR
    Maring, C.
    Wagner, R.
    Hutchinson, D.
    Flentge, C.
    Kati, W.
    Koev, G.
    Liu, Y.
    Beno, D.
    Shen, J.
    Lau, Y. Y.
    Gao, Y.
    Fischer, J.
    Vaidyanathan, S.
    Lim, B. H.
    Beyer, J.
    Mondal, R.
    Molla, A.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S347 - S347